Evidence map›Paper›PMID 41323376›Full record

ReviewFrontiers in oncology2025

AI-based prediction of pathological risk factors in lung adenocarcinoma from CT imaging: bridging innovation and clinical practice.

Yu Huang, Bowen Zhao, Ruiyang Yan, Chi Zhang, Zuhan Geng, Peiyuan Mei, Kuo Li, Yongde Liao

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu Huang *Department of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China.
Bowen Zhao *Department of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China.
Ruiyang Yan *School of Computer Science and Engineering, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Chi ZhangDepartment of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China.
Zuhan GengDepartment of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China.
Peiyuan MeiDepartment of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China.
Kuo LiDepartment of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China.
Yongde LiaoDepartment of Thoracic Surgery, Huazhong University of Science and Technology Tongji Medical College Union Hospital, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung adenocarcinoma (LUAD) is one of the main causes of cancer-related mortality worldwide. Pathological risk factors such as spreading through air spaces, high-risk pathological subtypes, occult lymph nodes, and visceral pleural invasion have significant impact on patient prognosis. In recent years, there has been significant progress in the application of artificial intelligence (AI) technology, e.g., deep learning (DL), in medical image analysis and pathological diagnosis of lung cancer, offering novel approaches for predicting the aforementioned pathological risk factors. This article reviews recent advancements in AI-based analysis and prediction of pathological risk factors in lung adenocarcinoma, with a focus on the applications and limitations of DL models, focusing on studies aimed at improving diagnostic accuracy and efficiency for specific high-risk pathological subtypes. Finally, we summarize current challenges and future directions, emphasizing the need to expand dataset diversity and scale, improve model interpretability, and enhance the clinical applicability of AI models. This article aims to provide a reference for future research on the analysis and prediction of pathological risk factors of LUAD and to promote the development and application of AI, especially DL, in this field.

Indexed as

artificial intelligencedeep learninghigh risk factorslung adenocarcinomapathology

Identifiers

PMID41323376
PMCPMC12658906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.